Literature DB >> 8586025

New potential uses for transdermal scopolamine (hyoscine).

M T La Rovere1, G M De Ferrari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8586025     DOI： 10.2165/00003495-199550050-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  41 in total

Review 1.  Pathophysiology of chronic heart failure.

Authors:  M Packer
Journal:  Lancet       Date:  1992-07-11       Impact factor: 79.321

2.  Effects of transdermal scopolamine on heart rate variability in normal subjects.

Authors:  T Vybiral; R J Bryg; M E Maddens; S S Bhasin; S Cronin; W E Boden; M H Lehmann
Journal:  Am J Cardiol       Date:  1990-03-01       Impact factor: 2.778

3.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.

Authors:  R E Kleiger; J P Miller; J T Bigger; A J Moss
Journal:  Am J Cardiol       Date:  1987-02-01       Impact factor: 2.778

4.  Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction.

Authors:  E Vanoli; G M De Ferrari; M Stramba-Badiale; S S Hull; R D Foreman; P J Schwartz
Journal:  Circ Res       Date:  1991-05       Impact factor: 17.367

5.  The long-term increase of baseline and reflexly augmented levels of human vagal-cardiac nervous activity induced by scopolamine.

Authors:  M E Dibner-Dunlap; D L Eckberg; N M Magid; N M Cintrón-Treviño
Journal:  Circulation       Date:  1985-04       Impact factor: 29.690

6.  Transdermal scopolamine use in the control of narcotic-induced nausea.

Authors:  F D Ferris; I G Kerr; M Sone; M Marcuzzi
Journal:  J Pain Symptom Manage       Date:  1991-08       Impact factor: 3.612

7.  The effects of transdermal scopolamine on autonomic nervous activity during sleep.

Authors:  J Alihanka; A Lahdenperä; T Kaila
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

8.  Effects of low dose transdermal scopolamine on heart rate variability in acute myocardial infarction.

Authors:  T Vybiral; D H Glaeser; G Morris; K R Hess; K Yang; M Francis; C M Pratt
Journal:  J Am Coll Cardiol       Date:  1993-11-01       Impact factor: 24.094

9.  Opposing central and peripheral effects of atropine on parasympathetic cardiac control.

Authors:  P G Katona; D Lipson; P J Dauchot
Journal:  Am J Physiol       Date:  1977-02

10.  Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.

Authors:  W N Leimbach; B G Wallin; R G Victor; P E Aylward; G Sundlöf; A L Mark
Journal:  Circulation       Date:  1986-05       Impact factor: 29.690
View more
  3 in total

1.  Adrenomedullin upregulates M2-muscarinic receptors in cardiomyocytes from P19 cell line.

Authors:  Sophie Buys; Fatima Smih; Atul Pathak; Pierre Philip-Couderc; Patrick Verwaerde; Jean-Louis Montastruc; Philippe Rouet; Jean-Michel Senard
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

2.  Mechanisms underlying rapid experience-dependent plasticity in the human visual cortex.

Authors:  B Boroojerdi; F Battaglia; W Muellbacher; L G Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-04       Impact factor: 11.205

Review 3.  Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions.

Authors:  Gaetano M De Ferrari; Peter J Schwartz
Journal:  Heart Fail Rev       Date:  2011-03       Impact factor: 4.214
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.